This is not the most recent version of the article. View current version (4 AUG 2010)

Intervention Review

Tyrosine supplementation for phenylketonuria

  1. Vanessa J Poustie1,*,
  2. Patricia Rutherford2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 21 AUG 2005

DOI: 10.1002/14651858.CD001507

Database Title

Additional Information

How to Cite

Poustie VJ, Rutherford P. Tyrosine supplementation for phenylketonuria. Cochrane Database of Systematic Reviews 1999, Issue 2. Art. No.: CD001507. DOI: 10.1002/14651858.CD001507.

Author Information

  1. 1

    Royal Liverpool Children's Hospital NHS Trust, Institute of Child Health, University of Liverpool, Liverpool, Merseyside, UK

  2. 2

    Vitaflo International Ltd, Liverpool, Merseyside, UK

*Vanessa J Poustie, Institute of Child Health, University of Liverpool, Royal Liverpool Children's Hospital NHS Trust, Eaton Road, Liverpool, Merseyside, L12 2AP, UK. v.poustie@liv.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (04 Aug 2010)

View Full Article (HTML) Summary (58K)Standard (180K)Full (223K)

  1. Current Version

    Tyrosine supplementation for phenylketonuria

    Diana Webster and Joanne Wildgoose

    Article first published online: 4 AUG 2010 | DOI: 10.1002/14651858.CD001507.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Tyrosine supplementation for phenylketonuria

    Vanessa J Poustie and Patricia Rutherford

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD001507

View Full Article (HTML) Summary (58K)Standard (180K)Full (223K)